The study, published in JAMA, found these adverse gastrointestinal effects happen in non-diabetic patients using the drugs specifically for weight loss.
It’s a retroactive study comparing it to data from people taking bupropion-naltrexone.
People taking Semaglutide were five times more likely to drink alcohol, a common cause of pancreatitis, probably because naltrexone is used to treat alcoholism.
It’s a retroactive study comparing it to data from people taking bupropion-naltrexone.
People taking Semaglutide were five times more likely to drink alcohol, a common cause of pancreatitis, probably because naltrexone is used to treat alcoholism.